Multiple companies report Q2 2026 financial results and analyst updates

Several companies in the medical and service sectors reported financial updates and analyst revisions for the second quarter of 2026.

Tactile Systems Technology, Inc. reported a 9% year-over-year revenue increase to $85.7 million, with net income rising to $7.8 million. The company also announced an exclusive U.S. distribution agreement with ElastiMed, Inc. for the MyoSleeve wearable compression device and the commercial launch of its next-generation AffloVest system.

Taysha Gene Therapies, Inc. held its Q2 2026 earnings call to discuss financial results and updates regarding its TSHA-102 program.

In the services sector, analysts at Stifel Nicolaus raised the price target for Aramark to $70.00, maintaining a “buy” rating. Similarly, TD Cowen lowered its price target for Stereotaxis from $5.00 to $3.00, though it maintained a “buy” rating for the medical robotics firm.